Danielle Bitterman, Assistant Professor at Harvard Medical School, shared a post on LinkedIn by National Comprehensive Cancer Network (NCCN), adding:
“Honored to have participated on the panel for NCCN’s discussion on AI in cancer care. I loved hearing all the incredible insights from wonderful colleagues and collaborators on how we balance AI innovations with safety, ethics, and equity. Thank you to NCCN and my fellow panelists for pushing the conversation forward.”
Quoting National Comprehensive Cancer Network (NCCN)‘s post:
“The NCCN Policy Summit focusing on the evolving artificial intelligence landscape in cancer care has begun! The morning panel is discussing AI’s expanding role in oncology and more. Tune in now.”
More posts featuring Danielle Bitterman on OncoDaily.
